Study shows broccoli may offer protection against liver cancer

Key points
- Consumption of broccoli has increased in the United States over the last few decades as scientists have reported that eating the vegetable three to five times per week can lower the risk of many types of cancer including breast, prostate, and colon cancers.
- "The normal story about broccoli and health is that it can protect against a number of different cancers.
- Jeffery says that the majority of the U.S. population eats a diet high in saturated fats and added sugars.
- "We called this a Westernized-style diet in the study because we wanted to model how so many of us are eating today," Jeffery says.
Consumption of broccoli has increased in the United States over the last few decades as scientists have reported that eating the vegetable three to five times per week can lower the risk of many types of cancer including breast, prostate, and colon cancers.
A new study from the University of Illinois reports that including broccoli in the diet may also protect against liver cancer, as well as aid in countering the development of fatty liver or nonalcoholic fatty liver disease (NAFLD) which can cause malfunction of the liver and lead to hepatocellular carcinoma (HCC), a liver cancer with a high mortality rate.
"The normal story about broccoli and health is that it can protect against a number of different cancers. But nobody had looked at liver cancer," says Elizabeth Jeffery, a U of I emeritus professor of nutrition. "We decided that liver cancer needed to be studied particularly because of the obesity epidemic in the U.S. It is already in the literature that obesity enhances the risk for liver cancer and this is particularly true for men. They have almost a 5-fold greater risk for liver cancer if they are obese."
Jeffery says that the majority of the U.S. population eats a diet high in saturated fats and added sugars. However, both of these are stored in the liver and can be converted to body fat. Consuming a high-fat, high-sugar diet and having excess body fat is linked with the development of NAFLD, which can lead to diseases such as cirrhosis and liver cancer.
"We called this a Westernized-style diet in the study because we wanted to model how so many of us are eating today," Jeffery says.
Previous research suggests that broccoli, a brassica vegetable containing bioactive compounds, may impede the accumulation of fat in the liver and protect against NAFLD in mice. Therefore, Jeffery and her team wanted to find out the impact of feeding broccoli to mice with a known liver cancer-causing carcinogen. The researchers studied four groups of mice; some of which were on a control diet or the Westernized diet, and some were given or not given broccoli.
"We wanted to look at this liver carcinogen in mice that were either obese or not obese," Jeffery explains. "We did not do it using a genetic strain of obese mice, but mice that became obese the way that people do, by eating a high-fat, high-sugar diet."
Although the researchers were predominantly interested in broccoli's impact on the formation and progression of cancerous tumors in the liver, Jeffery explained that they also wanted to observe the health of the liver and how the liver was metabolizing lipids because of the high-fat diet. "There is almost no information about broccoli and high-fat associated diseases," she says.
The study shows that in mice on the Westernized diet both the number of cancer nodules and the size of the cancer nodules increased in the liver. But when broccoli was added to the diet, the number of nodules decreased. Size was not affected.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBlack women more likely to have dense breast tissue, study shows
New research finds that black women are more likely than white women to have dense breasts, potentially boosting their breast cancer risk. "Since breast density is associated with breast cancer risk, a better…
21 April 2015
NewsNew Waldenstrom's drug shows sustained benefit at two years
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two…
10 April 2015
NewsPalbociclib shows promise in patients with hormone-resistant breast cancer
Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast…
24 February 2015



